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CARDIOPULMONARY DISCIPLINE SCIENCE PLAN
1.0 INTRODUCTION
As the U.S. Space Program prepares for extended-duration space flights on the
Space Shuttle, on Space Station Freedom, and on exploration missions to the Moon
and Mars, life sciences research must provide an understanding of the physiological
changes that occur and develop effective countermeasures to any effects that may be
detrimental to the functional capacity, health, or well-being of crewmembers. Life
sciences research in the cardiopulmonary discipline must identify possible
consequences of space flight on the cardiopulmonary system, understand the
mechanisms of these effects, and develop effective and operationally practical
countermeasures to protect crewmembers inflight and upon return to a gravitational
environment.
The long-range goal of the NASA Cardiopulmonary Discipline Research Program is to
foster research to better understand the acute and long-term cardiovascular and
pulmonary adaptation to space and to develop physiological countermeasures to
ensure crew health in space and on return to Earth.
1.1 PURPOSE
The purpose of this Discipline Science Plan is to provide a conceptual strategy for
NASA's Life Sciences Division research and development activities in the
comprehensive area of cardiopulmonary sciences. It covers the significant research
areas critical to NASA's programmatic requirements for the Extended-Duration Orbiter,
Space Station Freedom, and exploration mission science activities. These science
activities include ground-based and flight; basic, applied, and operational; and animal
and human research and development. This document summarizes the current status
of the program, outlines available knowledge, establishes goals and objectives,
identifies science priorities, and defines critical questions in the subdiscipline areas of
both cardiovascular and pulmonary function. It contains a general plan that will be
used by both NASA Headquarters Program Offices and the field centers to review and
plan basic, applied, and operational (intramural and extramural) research and
development activities in this area.
2.0 BACKGROUND AND CURRENT KNOWLEDGE
Current knowledge about physiological changes associated with short-term and long-
term space flight is summarized in Appendix I, which is from S.oace Phvsioloav and
_, 2nd. edition by Drs. Nicogossian, Leach-Huntoon, and Pool.
2.1 CARDIOVASCULAR PHYSIOLOGY
Concerns about cardiovascular adjustments to weightlessness actually preceded
manned space flight. Fortunately, the dire predictions of circulatory failure and
pulmonary edema proved incorrect, and there have been virtually no clinically overt
adverse effects on the cardiovascular system during weightlessness. However, the
readjustment to gravity following flight is associated with a number of cardiovascular
problems. Crewmembers returning from both short- and long-duration space flights
undergo several changes in cardiovascular function, principally reduced orthostatic
tolerance and decreased aerobic exercise capacity. Although these changes may
pose a greater problem for future, longer duration flights, they are also a concern for
the current short-duration Shuttle missions. It is estimated that many returning Shuttle
crewmembers would have problems exiting the vehicle if an emergency egress were
required immediately after landing. This problem has been worsened by the use of the
bulky, heavy, partial-pressure Launch and Entry Suit (LES) now required for all post-
Challenger flights.
Various mechanisms for cardiovascular adjustments in microgravity have been
postulated: decreased intravascular volume, increased postflight venous pooling
because of both structural and reflex vascular changes in the blood vessels of the
splanchnic region and the lower extremities, and alterations in overall cardiovascular
reflex control. In-flight orthostatic tolerance was determined during the Skylab
missions by measuring heart rate and blood pressure during progressive levels of
lower body negative pressure (LBNP). Decreased tolerance occurred within days
after reaching orbit, and persisted, relatively unchanged, for the duration of the flight.
Exercise capacity during the Skylab flights was relatively well-maintained, although
maximal exercise capacity was not formally tested, and small decrements would not
have been detected. Despite the apparent inflight preservation of aerobic exercise
capacity, postflight capacity was significantly depressed. Substantial decreases in
capacity were also reported by the Soviets in their flights of 1-12 months. The
decrements were found even though postflight exercise testing has been performed in
a supine position to reduce the effects of vascular volume deficit and of blood pooling.
The time course of the recovery has not been well defined.
A variety of countermeasures has been instituted to counteract the cardiovascular
changes associated with space flight. Aggressive in-flight exercise programs seem to
be only partially effective. Soviet cosmonauts currently exercise daily during flight and
use oral saline loading and anti-g suits to minimize orthostatic intolerance postflight.
U.S. astronauts follow a similar program, although there is no formal requirement for
exercise during flight and both exercise and fluid loading regimens vary according to
crew preference. The Soviets also use daily LBNP with saline loading in the last 3
weeks of flight to improve orthostatic tolerance. According to their reports, some
improvement in orthostatic tolerance occurs, but substantial disability remains,
especially after flights of more than 2-3 weeks' duration.
Echocardiography has shown decreased chamber dimensions in crewmembers
inflight when referenced to supine, Earth-based control values; but blood pressure,
heart rate, and left ventricular volumes during flight are similar to those in upright
subjects. Furthermore, Soviet scientists have reported microvascular changes in rats
and monkeys flown in their COSMOS biosatellites for periods of up to 14 days. They
also report venous congestion and vascular hyperplasia in a variety of tissues,
including the heart, lungs, kidney, and meninges. These changes may be related to
the cephalad fluid shifts, facial edema, and increases in renal size seen in long-
duration human flights.
Arrhythmias have been reported in both U.S. and Soviet flights. Evidence from the
Apollo Program and sporadic monitoring on Space Shuttle flights suggests a low
incidence of arrhythmias during space flight. Increased plasma catecholamines
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associated with psychological stress; heavy upper-body isometric exercise required to
function in partial-pressure, soft-shell space suits; hypokalemia; hypercalcemia;
thermal loads; and other cardiac changes have been suggested as etiological factors.
But whether these factors have any arrhythmogenic role in space flight is unknown.
Recently concluded agreements for monitoring of both Soviet cosmonauts and U.S.
astronauts should provide additional information.
In addition to the obvious operational questions concerning cardiopulmonary
physiology in microgravity, there are a number of other questions that can be studied
best in microgravity. In the cardiovascular system, there appear to be changes in
reflex regulation of circulatory function after flights of only a few days' duration. Carotid
sinus response curves derived from heart rate changes associated with experimentally
altered carotid artery transmural pressures suggest a decreased baroreflex
responsiveness after flights of only 4-5 days' duration. Furthermore, the rapid
response of the cardiovascular system to the cephalad fluid shifts in microgravity
provides a unique opportunity to gain insight into several important cardiovascular
regulatory mechanisms.
Limited information is available on the effects of space flights over 6 months on
cardiovascular function.
2.2 PULMONARY PHYSIOLOGY
There have been no pulmonary problems associated with weightlessness per se,
although there are problems and concerns associated with exposure to toxins and
with operations in hypobaric or hyperoxic environments. Skylab studies showed only
small changes in spirometry and no change in pulmonary function or gas exchange
efficiency during submaximal exercise. The absence of clinical or operational
problems in flight associated with primary changes in pulmonary function has meant
that little research attention has been directed to this area. However, a recent
German/Soviet report of a drop in PO z of arterialized capillary blood during long-term
flight in Mir, and persistence of the hypoxemia for a brief period after landing, suggests
that research is overdue. Furthermore, Soviet scientists have observed significant
reductions in PaO2 in head-down-tilt experiments, suggesting PaO2 of crewmembers
may be changed in microgravity. Lung function can be altered by changes in vascular
pressures and volumes, and the lung can be damaged by inhaled gases, vapors, and
aerosols. Integrity and normalcy of the pulmonary system cannot be assumed simply
because of lack of symptoms or overt clinical signs. The absence of gravity also
provides a model for examining the effect of gravity on blood flow and ventilation
gradients on pulmonary function and cardiopulmonary interactions such as the nature
and determinants of cardiogenic oscillations or the effects of lung compliance on
ventricular filling and compliance. Some data related to ventilation-perfusion
relationships and cardiogenic oscillations during space flight were obtained on the
Spacelab Life Sciences - 1 mission and are currently being analyzed.
3.0 DISCIPLINE GOALS AND CRITICAL QUESTIONS
3.1 GOALS
The overall goals of the cardiopulmonary program are to:
3
Understand the acute and long-term cardiovascular and pulmonary
adaptation to space and readaptation to a gravity environment, including
the associated mechanisms.
Ensure adequate physiological countermeasures.
Specific questions related to cardiovascular and pulmonary physiology are listed
below. Both human and animal models will be needed in studies designed to answer
these questions. This plan incorporates recommendations from reports by the
Committee on Space Biology and Medicine (Goldberg), the NASA Life Sciences
Strategic Planning Study Committee (Robbins), and the Federation of American
Societies for Experimental Biology (FASEB) (see 6.0, Selected References).
3.2 CRITICAL QUESTIONS
3.2.1 Cardiovascular (in priority order)
. Of the various countermeasures available to combat adverse
cardiovascular effects on long- and short-duration missions, which are
most effective, when and how should they be applied, and in what
sequence? These include but are not limited to LBNP, fluid rehydration,
pharmacology, centrifugation, exercise and anti-g devices.
o What are the nature, time course, and sequence of cardiovascular
adjustments to space flight (acute, medium term, and long term)?
Characterization of these adjustments should include assessment of
hem.dynamic, electrophysiological, neurohumoral, endocrine,
histological, and molecular changes.
. What are the specific mechanisms underlying the orthostatic hypotension
observed after flight? What are the effective countermeasures for this?
. What are the cardiovascular responses to extravehicular activity (EVA) at
various levels of gravity (e.g., microgravity, planetary excursion)? What
factors influence the occurrence, magnitude, and sequence of these
responses?
. What is the relationship between the cardiovascular adjustments to
space flight and those occurring in Earth-based models such as bedrest,
immersion, and head-down tilt?
. Are the bar.reflexes modified by space flight and how do these affect
orthostatic tolerance? Are chemoreflexes and osmoreflexes modified by
space flight and how do these affect orthostatic tolerance?
o Is there an increase in cardiac arrhythmias associated with space flight
and, if so, what is the time course of their occurrence and what are the
specific mechanisms responsible for them?
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10.
11.
12.
13.
14.
15.
16.
17.
18.
What are the specific mechanisms underlying decreased aerobic
capacity observed after flight? Are these changes present during flight?
What are the effective countermeasures for this? What are the most
effective exercise protocols for minimizing loss of aerobic capacity? Can
exercise adequate for maintaining muscle and bone mass produce
cardiovascular adaptations to sufficiently reduce the loss of aerobic
capacity?
Do crewmembers become fully adapted to the weightless condition
during space flight? And does the extent of adaptation affect postflight
orthostatic tolerance?
How are countermeasures to adverse cardiovascular effects of long-
duration space flight affected by changes in fluid distribution and
metabolism?
Are there appropriate animal and/or computer models for studying each
functional element of cardiovascular adjustments to microgravity?
Following long-term space flight, are there delayed or persistent
consequences, either beneficial or harmful? As a corollary, are there
appropriate rehabilitative measures that should be applied both in the
near-term (hours to days) and long-term (months to years) after flight?
Since microgravity alters blood pressures and flows to some tissues,
what are the structural and functional consequences in these various
tissues and organ systems, including the myocardium, with long-duration
flights?
Does space flight affect cardiovascular aging or disease processes
commonly found in adults in a 1-g environment? How is subclinical
cardiovascular pathology (e.g., small atrial defects, mitral valve prolapse,
hypertension) affected by space flight? Do these same questions apply
to healing processes in various organs?
What, if any, cardiovascular morphological changes are associated with
acute or long-term exposure to space flight (e.g., effects of microgravity,
radiation, or environmental hazards in the spacecraft)?
Does atrophy of smooth muscle in the leg vasculature occur during long-
term space flight? How are vascular endothelial structure and function
altered by such exposure and what are the consequences?
What is the nature of the interplay between hemodynamic and
electrophysiological responses to space flight and how much of this is
reflex mediated?
What are the correlations between the physiological responses
demonstrated in the various microgravity study environments (e.g., KC-
135, COSMOS, Research Animal Holding Facility [RAHF]) that are
available?
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3.2.2
19. What is the nature, time course, and individual variability of recovery
following space flight? Is there a different sequence in the adaptive
events during this period for different individuals and, if so, are they age
or sex related? What, if any, are the cumulative effects of multiple
mission exposures?
20. For the well-documented changes in calcium metabolism associated with
space flight, what are the direct and indirect consequences for electrical,
mechanical, and vascular events in the heart and for the vascular
system?
21. What is the relationship between cardiovascular response and exposure
to varying gravity levels (force, time)? Is there a threshold?
22. Are there appropriate controls for these microgravity studies and, if so,
what are they?
23. What is the relationship of cardiovascular adjustments to those produced
by microgravity in other systems and vice versa?
24. What is the nature of microgravity-associated changes in the
autoregulatory mechanisms of capillaries, arterioles, venules, and
lymphatics? What role do these changes play in the adaptation to
microgravity and return to normal gravity?
25. What is the nature of space-flight-induced changes in the secretion or
effect of vasoactive substances, and what is the effect of duration of
exposure to microgravity?
26. Are there changes in cardiac performance and contractile efficiency
during exposure to microgravity?
27. Does redistribution of blood volume and flow during space flight affect
pH, PO2, or PCO2, or HCO3 in tissues of any organs and vice versa?
28. Are there cellular and subcellular changes in cardiac function? Are there
changes in myocardial contractile proteins? Is there a change in
excitation-contraction coupling mechanisms induced by space flight?
Pulmonary
(in priodty order)
° What are the risks for bubble formation and clinical decompression
sickness associated with various pre-EVA denitrogenation/decompression
schedules?
= In the environment of microgravity, does the absence of sedimentation
cause deeper penetration by aerosol particles in the lung? In the
spacecraft environment, what are the aerosol concentrations, particle
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11.
12.
13.
14.
size profiles, and bacterial contaminations? Do these factors constitute a
health hazard?
Which pulmonary life support procedures should be used for effective
protection or resuscitation of crewmembers in the event of loss of
pressure in the EVA suit or cabin?
How do the combined influences of exercise, oxygen breathing, and
pulmonary microvascular gas emboli affect pulmonary function (including
PaO2, PaCO2, pH, HCO3, hemoglobin, and hematocrit) during and after
EVA ?
Does space flight affect pulmonary aging or disease processes
commonly found in adults in a 1-g environment? How is subclinical
pulmonary pathology (e.g., incipient bronchospasm, early emphysema)
affected by space flight? Do these same questions apply to healing
processes in the lung?
Is pulmonary function altered in long-duration space flight?
Are there appropriate animal and/or computer models for studying each
functional element of pulmonary adjustments to microgravity?
What is the relationship, if any, between the pulmonary adjustments to
space flight and those occurring in Earth-based models such as bedrest,
immersion, and head-down tilt?
Is the inequality of ventilation and blood flow, and its effects on gas
exchange, altered by exercise in microgravity?
Are there changes in respiratory muscle structure and function in space
flight, and do such changes affect maximal oxygen uptake?
To what extent do lung volumes change in microgravity, and specifically
how far does functional residual capacity decrease? Do these changes
in lung volumes affect pulmonary gas exchange? Do additional lung
volume changes occur during sleep in microgravity and thus affect gas
exchange? What is the effect of functional residual capacity (FRC)
reduction on tolerance to 100-percent oxygen breathing before and
during EVA?
What changes occur in rib cage, diaphragm, and abdominal wall
configurations during microgravity?
What happens to the gravity-determined topographical differences in
blood flow, ventilation, alveolar size, intrapleural pressures, diffusion and
mechanical stresses in microgravity, and how do these affect pulmonary
gas exchange? Are there non-gravity-determined residual inequalities?
Does space flight affect central and/or peripheral respiratory control
mechanisms? Are there factors in the space flight environment that
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15.
16.
17.
18.
significantly influence the control of breathing? Are spacecraft CO2
levels sufficiently low to preclude the development of acidosis, CO2
retention and metabolic consequences, especially via renal and bone
mechanisms?
Does space flight alter nonventilatory pulmonary function, e.g., immune,
hormone, or enzyme mechanisms? Does this bear special relevance to
the processing of and response to aerosolized antigenic stimuli?
If fluid transudation does occur, is this affected by exercise or other
countermeasures, and is gas-exchange affected?
What is the combined effect of changes in lung volumes and alterations
in mechanical stress and intrapleural pressure on the pericardial
pressure in microgravity? What practical steps should be made to
reference thoracic intravascular pressures to transvascular pressures?
To what extent are pulmonary vascular and microvascular pressures and
interstitial fluid-lymphatic transport altered by microgravity? Are there
any clinically significant consequences of these changes and what are
they?
4.0 TECHNOLOGY
There are several technological requirements that are critically needed for conducting
cardiopulmonary research in microgravity. Much of the hardware needed for human
research is already available for laboratory or clinical use, but flight-qualified units
should be developed. As a general principle, noninvasive monitoring devices are
usually preferable. The need for flight equipment and facilities for animal research is
even greater. Unavailability of cardiovascular sensors remains a key limiting factor,
particularly for animal studies. The following is a table of critical technologies.
Table 1
WORKING LIST OF HARDWARE
CARDIOVASCULAR
. Pressure transducers
a. Human
Improved automatic cuffs
Smaller, reliable, digital pressure
Beat-to-beat blood pressure, e.g., calibrated applanation
tonometer
Improved central venous pressure
Device to measure vascular capacitance noninvasively
b. Animal
More reliable biosensors
Develop technology for external barometric reference for
implantable transducer
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Develop transducers for chronic implantation which would
allow measurement of pleural and airway pressures
Technique for reliable long-term pericardial pressure recording
CSF transducer technology
Intracranial pressure transducer technology
Develop implantable telemetry units that could be used for
changes in dimensions, temperatures, flows, pressures, etc.
Flow
a.
b.
Human
Improved accuracy for cardiac output determination
1. Foreign gas/rebreathing
2. Indicator dilution method
3. Doppler
4. Isotopes
Develop/obtain techniques for regional flow determinations
(e.g., laser Doppler, plethysmograph, NIR)
Animal
Improved flow transducer (Doppler or EMF)
Method to record venous return accurately
Coronary sinus flow recording
Dimensions/volumes
a. Human
Improved echo cardiac and vascular imaging technique
Improved technique for body segment volumes
Radionuclide technologies and other techniques for blood
volumes
b. Animal
Implantable conductance technique (volume)
Improved sonomicrometry techniques
Radionuclide
Electrophysiology
a. Human
In-flight high-resolution, multi-lead ECG, with real-time
processing/data compression
Telemetry ECG
b. Animals
Electropotential transducer
Improved radiotelemetry ECG
Telemetry controllable pacing system
Improved LBNP device capable of sinusoidal pressures
Calibrated exercise devices
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PULMONARY
Respiratory gas analysis
Blood gas analysis
Gravity-independent flow meters
Gas storage, mixing, and delivery system
Hemoglobin/oxygen saturation telemetry system
Aerosol production and delivery system
GENERIC
Devices to measure body mass, volume, and surface area in humans
and animals
Device to measure and collect urine
Intravenous infusion kit, pump
Improved kits to collect, process, and store blood, including centrifuge,
freezer,
trash capability
Glovebox workstation that allows handling of animals, specimens,
toxic/hazardous materials (e.g., glutaraldehyde, isotopes, biohazards)
Freezers and refrigerators
Waste storage system for biohazards
Implantable chemosensors (e.g. for Ca ++)
Method to handle and inject isotopes
4.1 ACCURATE MEASURE OF CARDIAC OUTPUT FOR BOTH HUMANS AND
ANIMALS
Current methods for determining cardiac output include foreign gas rebreathing,
echocardiography, Doppler ultrasound, and impedance cardiography for humans, and
implantable Doppler and electromagnetic flow probes in animals. The most
appropriate technique depends on the specific circumstances during the
measurement. A remaining problem is the frequent operational instability of
biosensors used in animal studies. Because of their greater accuracy at present,
foreign gas rebreathing methods for determining cardiac output in humans should be
implemented for all pre- and postflight testing. Because of current logistical
constraints, less complicated methods are still required for in-flight monitoring.
4.2 ACCURATE MEASURE OF HEART RATE AND BLOOD PRESSURE
Several techniques permit measurement of beat-to-beat systemic arterial pressure.
Records of ECG and beat-to-beat blood pressure could be analyzed for first order
hemodynamics, variability, spectral content, power, etc., and correlated with other
indices of cardiopulmonary function. Noninvasive blood pressure measurement
systems recently adapted for flight use by the Johnson Space Center should provide
accurate measurements, and these systems merit implementation.
Some investigations will require technology not presently available, which includes
the need for calibrated, noninvasive, continuous recording of blood flow and pressure,
radiotelemetry techniques, and a technique for pleural pressure recording.
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Respiratory gas measurements are critical for most pulmonary function studies.
Equipment such as light-weight, stable mass spectrometers and ultrasonic flow meters
is complex, but should be obtained and modified for flight.
5.0 RESEARCH STRATEGY
The cardiopulmonary research area priorities for each of the NASA mission eras are
presented in Table 2.
Table 2a
RANKINGS OF RESEARCH AREA PRIORITIES FOR EACH MISSION ERA
CARDIOVASCULAR
STS ERA
CURRENT
1992-1995
OrthostatJcTo4erance
Countermeasures
Electrophysiology
(Arrhylhmias1
Work Capac_y(Exercise, Aerobic
Training,EVA1
Integrated Studies
SPACE STATION
ERA
1991-2000
EXPLORATION
ERA
2000-3000
Hemodynami¢Mechanisms 4.5 3.5 3
(Orthostati¢ Tolerance)
1 2 1.5
2.5 3.5 6
2.5 1 1.5
6 6.5 5
Validationof Modelsand 4.5 5 7.5
Controls
Morphological& Microcirculatory 7 8 7.5
Cellular/Biochemical 9 9 9
MedicalIssues 8 6.5 4
Table 2b
PULMONARY
PulmonaryFunction
Moq:>hological&
Mictocirculatoty
LongDepo_lion
of Aerosols
STS ERA
CURRENT
1992-1995
7
SPACE STATION
ERA
1991-2000
5.5
7
EXPLORATION
ERA
2000-3000
1.5
EVA/Den_ogenalion 1 1 1.5
IntegratedStudies 5.5 5.5 6
Validation of Modelsand Controls 3 4 5
Medical Issues 5.5 3 3
The research plan incorporates a balanced program of both basic and applied efforts
conducted in parallel. Although hypotheses concerning countermeasures against
adverse cardiovascular effects have their foundation in ground-based physiology,
space flight studies will serve to validate and refine Earth-based models. An
integrated approach merging human and animal experimentation and computer
modelling should be implemented. The basic science issue centers on understanding
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short- and long-term cardiovascular adaptation to microgravity and readaptation to
gravity conditions of 1-g or greater. The applied science concern focuses on the
countermeasures needed to maximize crew health and safety and optimize
performance. Countermeasures should be based on sound physiological principles
and be testable by objective criteria and statistical approaches. To date, most of the
in-flight investigations of cardiopulmonary function have tended to ask practical,
operationally relevant questions. As the safety of crewmembers with regard to
cardiovascular function for short-duration missions becomes apparent, the opportunity
to address many of the cardiopulmonary questions from a more basic, mechanistic
approach will increase. It is clear that many of these physiological questions can be
answered only by taking a "systems" approach, although careful study and
understanding of pressure and flow to the various organs will be an important
component of such an overall approach.
An accessible data base is the first component needed to develop a comprehensive
program in cardiopulmonary space physiology. Research from space medicine must
be designed and conducted in a manner that will encourage publication in widely
distributed, peer reviewed publications.
Orthostatic intolerance and diminished exercise capacity remain significant problems
after flight. To approach this problem, a high priority must be given to systematic data
collection, especially directed toward identifying specific predisposing cardiovascular
changes and their underlying mechanisms. Blood pressure and heart rate are usually
measured manually in both the U.S. and Soviet programs. A simple, single-channel
ECG with beat-to-beat blood pressure monitoring would give important new
information regarding the extent and time course of the readaptation process. High
quality recording of the ECG would allow spectral analysis and correlation with
changes in simultaneously measured blood pressure (vide infra). Those simple
parameters, combined with cardiac output measurements (CO2 or foreign gas
rebreathing) and forearm skin blood flow determination, conducted supine and
standing, would answer the question as to whether vasoconstriction and tachycardia
occur appropriately, or if important reflex mechanisms are changed. Blood volume
determination, coupled with measures of plasma catecholamines, would provide
information regarding volume status and neurohumoral responsiveness. Current
measures of carotid baroreflex sensitivity should be continued until sufficient numbers
of subjects are obtained to permit analysis, but correlative data regarding cardiac
output, stroke volume, and peripheral resistance must be obtained for a "system" level
interpretation. Functions of the aortic baroreceptor reflexes should also be assessed.
Further studies to quantify postflight venous pooling in the legs should be continued as
well. Maximal exercise capacity should be assessed in conjunction with other
cardiovascular and musculoskeletal testing. Such a coordinated approach is required
to distinguish cardiovascular and skeletal muscle components of any observed
deconditioning. A suitable protocol for this purpose could be conducted on an
appropriate number of crewmembers in pre- and immediate postflight periods.
Associated ground-based studies must address the body's handling of saline and
other fluid-loading interventions, as well as the effects of LBNP on intravascular
volume retention, orthostatic intolerance, and upright exercise capacity. Additional
studies must also examine whether changes in the microvasculature are responsible
for alterations in fluid volume distribution, tissue pressure, and blood flow associated
with cardiovascular adjustments to microgravity and return to Earth. There are virtually
12
no data on changes in vascular permeability, tone, structural integrity or endothelial
function following exposure to microgravity, despite widespread clinical recognition of
in-flight problems such as facial edema, persistently cold lower extremities, and a 10-
15 percent decrease in calf volume, as well as lower extremity petechiae, which
appear after completion of long-duration flights.
Arrhythmias have been a concern in both U.S. and Soviet crewmembers, yet there is
limited information regarding the actual prevalence of arrhythmias in any phase of
Shuttle flight other than during extravehicular activity (EVA). The frequency of
arrhythmias in crewmembers should be determined before, during, and immediately
after flight. Appropriate aeromedical assessment methods and interventions could
then be developed on the basis of the data obtained.
It is possible that there are no ideal ground-based models for space-flight-induced
cardiovascular changes. Currently used ground-based models include supine and 5-
to 7-degree head-down bedrest, immersion, and lower body positive pressure. Soviet
scientists have reported that "anti-orthostatic bedrest" (5-degree to 7-degree head-
down tilt) is a satisfactory model of the changes associated with microgravity, but there
is a need for additional flight data to substantiate this hypothesis. The Spacelab Life
Sciences 1 (SLS-1) mission included head-down tilt studies on the flight crews, as
does SLS-2. Head-down-tilt studies should be the same duration as the flights.
These studies should provide a more direct assessment of the validity of the head-
down-tilt model. These studies test some of the hypotheses regarding acute fluid
shifts, but will not simulate the adjustments expected after extended-duration flights. If
short-term data indicate validity of the hypothesis, a mission-length study postflight
should be given high priority to provide a more rigorous test of the head-down tilt
model.
Many questions relating to cardiovascular physiology may be addressed in man by
noninvasive technologies. Other indices of performance of the cardiovascular system,
however, require some information relating to pressure and flow as well as volume or
dimension. In some cases, morphological or histochemical data are required.
Because of ethical and engineering constraints, many of these data are not easily
collected in humans and therefore require an animal model. Since baroreflex
mechanisms are thought to be important for many of the in-flight and postflight
changes observed in cardiovascular performance, it is important to choose an animal
model with baroreflexes as similar to man as possible. For this reason, primates have
a distinct advantage over quadripeds. Furthermore, certain primate species have
cardiovascular hemodynamic properties that mimic those of humans. Chronically
instrumented primates have been used for ground-based studies in aerospace
cardiovascular research, and a limited degree of instrumentation has been performed
on COSMOS biosatellites. A primate fully instrumented for multiple invasive
cardiovascular variables has not been subjected to actual space-flight studies.
Research should be conducted to further develop biosensors that are conducive to
chronic instrumentation in animal models. More stability of transducers, improved
biotelemetry systems, and new techniques of implantation, maintenance, and
calibration may be required. Furthermore, animal models may be utilized to help
validate Earth-based models of space-flight effects and computer models of
cardiovascular function for these environments.
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Clearer definitions and descriptions of potential applicability of animal experiments or
computer simulations of the human space experience are needed. This applies to
both cardiovascular and pulmonary changes. Opportunities on KC-135 parabolic
flights and biosatellite flights as well as the primate RAHF and RHESUS programs for
Spacelab, should be developed to examine cardiopulmonary changes in rats, as well
as squirrel and rhesus monkeys. The findings from these experiments and the
experience gained in developing flight hardware should be useful in planning
research to be performed on future Spacelab flights and on Space Station Freedom,
both in the pre-Permanently-Manned-Capability facilities and later in the Space
Physiology Laboratory.
Countermeasures against microgravity-induced cardiovascular changes are currently
being employed by both the U.S.S.R. and U.S. programs, but a strong physiological
basis for these interventions is lacking. Both programs use fluid loading immediately
prior to re-entry, but the optimal formulation of the composition of the solution, its
amount, and the timing of administration are uncertain. Likewise, additional data are
needed to support the extensive inflight use of lower body negative pressure. A
similar need for physiological data exists with respect to the type and amount of inflight
exercise needed. A systematic approach to the assessment of the various
components of existing countermeasures and the development of new ones is badly
needed.
The use of venous-occlusion thigh cuffs to mimic gravity-induced pooling of blood in
the lower extremities has been mentioned by the Soviet scientists as an anti-
orthostatic countermeasure. There are unsubstantiated reports that Soviet
cosmonauts have worn occlusion cuffs during long-duration flights with excellent
responses in terms of transient relief of facial edema, cephalad fluid shifts, and aerobic
deconditioning. Such a countermeasure may be particularly well-suited for the short-
term flights planned for the Space Shuttle over the next 2-3 years. As with the other
"countermeasures," appropriate physiological measurements must be made to
determine both the beneficial and possible harmful effects of this intervention.
The absence of gravity also provides a model for examining cardiopulmonary
interactions, such as the nature and determinants of cardiac pulsatile action on small
airway function.
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